Home › Legal › Cannabis Advertising Restrictions in Portugal
⚐ Flag an error How this page was made
Also known as: Portuguese cannabis advertising ban · Portugal cannabis marketing restrictions

Cannabis Advertising Restrictions in Portugal

Medical cannabis ads to consumers are banned; recreational cannabis sale is criminal, so promotion is also prohibited.

Automated fact-check pass
7 cited sources
Published
Last reviewed
How this page was made

This article is general information, not legal advice. Laws change; check current rules with official sources or a lawyer.

↯ The honest take

Portugal treats medical cannabis like any other prescription medicine — no consumer ads allowed. Recreational cannabis remains illegal to sell, so advertising it is doubly prohibited. The grey zone is non-medicinal CBD and hemp products: if you make a health claim, they flip into medicines law. Enforcement against cannabis specifically is limited in public records, but regulators have the statutory tools and use them against other medicines.

Portugal's cannabis advertising rules depend on which law governs the product.

Recreational cannabis is a controlled substance under Decree-Law 15/93 [1]. Sale and trafficking are criminal offences. Personal possession of small quantities was decriminalised (not legalised) by Law 30/2000 [2] — it remains an administrative matter, not a basis for legal commerce or promotion.

Medical cannabis was authorised by Law 33/2018 of 18 July 2018 and implemented by Decree-Law 8/2019 [3][4]. Products, cultivation, and dispensing are supervised by Infarmed (Autoridade Nacional do Medicamento e Produtos de Saúde).

General advertising law is governed by the Código da Publicidade (Decree-Law 330/90) [5], while medicines-specific rules are in Decree-Law 176/2006, the Estatuto do Medicamento [6].

Because medical cannabis preparations are dispensed only by prescription, they are captured by the prescription-medicine advertising regime — which is where the restrictions bite. Strong evidence

Consumer Advertising: What Is Prohibited

Medical cannabis and prescription medicines. Article 150 of Decree-Law 176/2006 prohibits advertising of prescription-only medicines to the general public [6]. Infarmed confirms this includes cannabis-based medicines and preparations authorised under Law 33/2018.

This means:

Recreational cannabis. Advertising is not merely restricted—the underlying activity (sale) is criminal, so any advertising would also breach Article 8 of the Advertising Code (Decree-Law 330/90), which forbids promoting illegal goods or services [5]. Strong evidence

Grey zones. Coffeeshop-style marketing, cannabis-club promotion, and "grow shop" advertisements that hint at personal cultivation for consumption sit in a legally exposed grey area. Enforcement has been inconsistent Weak / limited, but the statutory position is clear.

What Is Allowed

Healthcare professional advertising. Under Articles 153–157 of Decree-Law 176/2006, promotion of prescription medicines to doctors, pharmacists, and other prescribers is permitted if it is truthful, evidence-based, references the approved product information, and is not disguised as consumer content [6]. Infarmed may inspect materials and enforce compliance.

Institutional and scientific communication. Companies may publish scientific data, participate in medical conferences, and respond to unsolicited requests for information. General corporate communications that do not promote a specific product to consumers typically fall outside the advertising ban.

Non-medicinal hemp and CBD products. Cosmetics containing cannabidiol can be marketed if they comply with EU Regulation 1223/2009 and make no medicinal claims. CBD foods and supplements remain restricted under the EU Novel Food framework; the European Commission classifies most CBD extracts as novel foods requiring pre-market authorisation, and Portuguese authorities follow that position Strong evidence. Making any therapeutic or health claim about a CBD product reclassifies it as a medicine and brings it under Decree-Law 176/2006.

Regulators and Enforcement

Three main regulators enforce advertising rules:

Criminal penalties under Decree-Law 15/93 apply where advertising promotes trafficking or illicit sale [1]. Infarmed maintains a record of sanctions against unauthorised medicine promotion generally; however, publicly available cases naming cannabis products specifically are limited Weak / limited.

Recent Developments

Last verified: 31 October 2026. Check Infarmed and the Diário da República for updates before relying on this article.

Practical Checklist

If you are a company operating in or into Portugal:

  1. Classify the product: medicine, cosmetic, food/supplement, or industrial hemp. Advertising rules follow the classification.
  2. If it is a medicine: assume no consumer advertising. Any materials for healthcare professionals must be pre-cleared internally against Infarmed guidance.
  3. Avoid therapeutic claims on any non-medicinal cannabis or CBD product. A single phrase such as "relieves pain" or "reduces inflammation" can reclassify the product as a medicine.
  4. Remember territorial scope: Portuguese law applies to advertisements targeted at Portuguese consumers regardless of where the platform or content creator is based.
  5. Keep records: Infarmed and DGC can request substantiation of claims.

---

This is not legal advice. Cannabis and advertising law in Portugal is technical and subject to regulatory interpretation. Consult a Portuguese lawyer with experience in medicines and advertising law before publishing or promoting any cannabis or CBD product.

Sources

  1. Government Decreto-Lei n.º 15/93, de 22 de janeiro — Regime jurídico do tráfico e consumo de estupefacientes e substâncias psicotrópicas. Diário da República.
  2. Government Lei n.º 30/2000, de 29 de novembro — Descriminalização do consumo de estupefacientes e substâncias psicotrópicas. Diário da República.
  3. Government Lei n.º 33/2018, de 18 de julho — Utilização de medicamentos, preparações e substâncias à base da planta da canábis para fins medicinais. Diário da República.
  4. Government Decreto-Lei n.º 8/2019, de 15 de janeiro — Regulamentação da Lei n.º 33/2018 sobre canábis para fins medicinais. Diário da República.
  5. Government Decreto-Lei n.º 330/90, de 23 de outubro — Código da Publicidade. Diário da República.
  6. Government Decreto-Lei n.º 176/2006, de 30 de agosto — Estatuto do Medicamento (Título IX: Publicidade). Diário da República.
  7. Reported Reuters — Portugal parliament rejects bills to legalise recreational cannabis (2021).

How this page was made

Generation history

Oct 31, 2026
Fact-check pass — raised 11 flags
Oct 31, 2026
Revision
Jul 21, 2026
Fact-check pass — raised 1 flag
Jul 21, 2026
Initial draft

Drafted with AI assistance and checked by a separate automated fact-check pass. Not every article has been read by a person. See how articles are made.